Healthcare | February 15, 2022
USFDA grants Breakthrough Designation for Datar’s early-stage prostate cancer detection blood test
Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
_256_275.jpg)